Tofersen approved by the MHRA to treat rare inherited form of motor neurone disease

List of Field Safety Notices from 11 to 15 August 2025.

Annual Report of the Human Medicines Regulations 2012 Advisory Bodies – the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.

List of Field Safety Notices from 24 to 28 November 2025.

Hikma Farmacêutica (Portugal) S.A has informed the MHRA that the Patient Information Leaflet (PIL) contained within batch CB0033 of Gemcitabine 2g/52.6ml concentrate for solution for infusion does not contain the side effects of serious skin reactions.

How to change the ownership from one marketing authorisation (MA) holder to another.

How to register your medical devices with the MHRA for the markets in Great Britain and Northern Ireland.